Verfaillie CM - Search Results

1

Pluripotency of mesenchymal stem cells derived from adult marrow.

Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. Jiang Y, et al. Among authors: verfaillie cm. Nature. 2002 Jul 4;418(6893):41-9. doi: 10.1038/nature00870. Epub 2002 Jun 20. Nature. 2002. PMID: 12077603 Free article.

2

Can human hematopoietic stem cells be cultured ex vivo?

Verfaillie CM. Verfaillie CM. Stem Cells. 1994 Sep;12(5):466-76. doi: 10.1002/stem.5530120503. Stem Cells. 1994. PMID: 7528589 Review.

3

Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro.

Verfaillie CM, Catanzarro PM, Li WN. Verfaillie CM, et al. J Exp Med. 1994 Feb 1;179(2):643-9. doi: 10.1084/jem.179.2.643. J Exp Med. 1994. PMID: 8294873 Free PMC article.

4

The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro.

Punzel M, Wissink SD, Miller JS, Moore KA, Lemischka IR, Verfaillie CM. Punzel M, et al. Among authors: verfaillie cm. Blood. 1999 Jun 1;93(11):3750-6. Blood. 1999. PMID: 10339481 Free article.

5

Opposing effects of engagement of integrins and stimulation of cytokine receptors on cell cycle progression of normal human hematopoietic progenitors.

Jiang Y, Prosper F, Verfaillie CM. Jiang Y, et al. Among authors: verfaillie cm. Blood. 2000 Feb 1;95(3):846-54. Blood. 2000. PMID: 10648395 Free article.

6

Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34+ cell proliferation: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27Kip, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity.

Jiang Y, Zhao RC, Verfaillie CM. Jiang Y, et al. Among authors: verfaillie cm. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10538-43. doi: 10.1073/pnas.190104497. Proc Natl Acad Sci U S A. 2000. PMID: 10973491 Free PMC article.

7

Kinetics of engraftment of CD34(-) and CD34(+) cells from mobilized blood differs from that of CD34(-) and CD34(+) cells from bone marrow.

Verfaillie CM, Almeida-Porada G, Wissink S, Zanjani ED. Verfaillie CM, et al. Exp Hematol. 2000 Sep;28(9):1071-9. doi: 10.1016/s0301-472x(00)00506-3. Exp Hematol. 2000. PMID: 11008020 Free article.

8

A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector.

Zhao RC, Jiang Y, Verfaillie CM. Zhao RC, et al. Among authors: verfaillie cm. Blood. 2001 Apr 15;97(8):2406-12. doi: 10.1182/blood.v97.8.2406. Blood. 2001. PMID: 11290604 Free article.

9

Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system.

Lewis ID, Almeida-Porada G, Du J, Lemischka IR, Moore KA, Zanjani ED, Verfaillie CM. Lewis ID, et al. Among authors: verfaillie cm. Blood. 2001 Jun 1;97(11):3441-9. doi: 10.1182/blood.v97.11.3441. Blood. 2001. PMID: 11369635 Free article.

10

Novel therapies for chronic myelogenous leukemia.

Jahagirdar BN, Miller JS, Shet A, Verfaillie CM. Jahagirdar BN, et al. Among authors: verfaillie cm. Exp Hematol. 2001 May;29(5):543-56. doi: 10.1016/s0301-472x(01)00633-6. Exp Hematol. 2001. PMID: 11376866 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

425 results

Search Page